Search results: Sage Journals

Restricted accessResearch articleFirst published November, 1998

Comparative Study of the Pharmacodynamic and Pharmacologic Effects of Betaseron ® and AVONEX ™

Gary J. Williams, Patricia L. Witt

Journal of Interferon & Cytokine Research

Restricted accessResearch articleFirst published January, 1995

The Use of Zwittergent 3-14 in the Purification of Recombinant Human Interferon-β Ser 17 (Betaseron)

Dean Russell-Harde, Melissa Knauf, ED Croze

Journal of Interferon & Cytokine Research

Restricted accessResearch articleFirst published December, 1996

A therapeutic and economic assessment of betaseron® in MS

M G Brown, T J Murray, J D Fisk [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published June, 2006

Interferon beta-1b (Betaseron®/Betaferon®) is well tolerated at a dose of 500 mg: interferon dose escalation assessment of safety (IDEAS)

M H Gottesman, S Friedman-Urevich

Multiple Sclerosis Journal

Restricted accessNewsFirst published March, 1994

{BLR 1652}Multiple Sclerosis - Betaseron - Berlex Laboratories - Accelerated Approval

Biotechnology Law Report

Restricted accessNewsFirst published September, 1994

{BLR 1841}Beta-Interferon - Betaseron - Biogen - Chiron - Multiple Sclerosis

Biotechnology Law Report

Restricted accessResearch articleFirst published December, 2001

A prospective,open-label treatment trial to compare the effect of IFNβ-1a (Avonex®),IFNβ-1b (Betaseron®),and glatiramer acetate (Copaxone®) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy

Omar A Khan, Alexandros C Tselis, John A Kamholz [...]

Multiple Sclerosis Journal

Restricted accessOtherFirst published May, 2007

Clinical relevance of anti-drug antibodies with interferon beta-1b therapy in multiple sclerosis

M. Cantillon, I. Antonijevic

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published June, 1996

Interferon β-1b: latest published results,1995

John H Noseworthy

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published April, 1993

Pharmacokinetics and Antiviral Activity of Recombinant Human Interferon-β ser17 in African Green Monkeys

Janie Chiang, Carol A. Gloff, Kenneth F. Soike [...]

Journal of Interferon & Cytokine Research

Restricted accessResearch articleFirst published November, 1998

Comparative Study of the Pharmacodynamic and Pharmacologic Effects of Betaseron ® and AVONEX ™

Gary J. Williams, Patricia L. Witt

Journal of Interferon & Cytokine Research

Restricted accessResearch articleFirst published January, 1995

The Use of Zwittergent 3-14 in the Purification of Recombinant Human Interferon-β Ser 17 (Betaseron)

Dean Russell-Harde, Melissa Knauf, ED Croze

Journal of Interferon & Cytokine Research

Restricted accessResearch articleFirst published December, 1996

A therapeutic and economic assessment of betaseron® in MS

M G Brown, T J Murray, J D Fisk [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published June, 2006

Interferon beta-1b (Betaseron®/Betaferon®) is well tolerated at a dose of 500 mg: interferon dose escalation assessment of safety (IDEAS)

M H Gottesman, S Friedman-Urevich

Multiple Sclerosis Journal

Restricted accessNewsFirst published March, 1994

{BLR 1652}Multiple Sclerosis - Betaseron - Berlex Laboratories - Accelerated Approval

Biotechnology Law Report

Restricted accessNewsFirst published September, 1994

{BLR 1841}Beta-Interferon - Betaseron - Biogen - Chiron - Multiple Sclerosis

Biotechnology Law Report

Restricted accessResearch articleFirst published December, 2001

A prospective,open-label treatment trial to compare the effect of IFNβ-1a (Avonex®),IFNβ-1b (Betaseron®),and glatiramer acetate (Copaxone®) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy

Omar A Khan, Alexandros C Tselis, John A Kamholz [...]

Multiple Sclerosis Journal

Restricted accessOtherFirst published May, 2007

Clinical relevance of anti-drug antibodies with interferon beta-1b therapy in multiple sclerosis

M. Cantillon, I. Antonijevic

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published June, 1996

Interferon β-1b: latest published results,1995

John H Noseworthy

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published April, 1993

Pharmacokinetics and Antiviral Activity of Recombinant Human Interferon-β ser17 in African Green Monkeys

Janie Chiang, Carol A. Gloff, Kenneth F. Soike [...]

Journal of Interferon & Cytokine Research